Figure S5 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy Article Swipe

View

Galen Hostetter , Justin R. Kulchycki , R. Katherine Alpaugh , Candice L. Schwebel , Pooja Ghatalia , Jozef Madžo , Noah M. Hahn , Jean‐Pierre J. Issa , Stephen B. Baylin , Hui Shen , Peter A. Jones ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.30707747

Supplementary Figure 5: Overall tumor mutation burden and frequency of mutations in cancer-associated genes in UC tumors.

Related Topics

My Love From The Star

Throw Momma From The Train

Tales From Topographic Oceans

Deliver Us From Evil (2014 Film)

Ruth (Biblical Figure)

From Under The Cork Tree

From Hell Letter

Away From Her

Tales From The Borderlands

The Girl From Everywhere

The View From Saturday

Suicide Notes From Beautiful Girls

Concepts

No concepts available.

Metadata

Type: article
Landing Page: https://doi.org/10.1158/1078-0432.30707747
OA Status: gold
OpenAlex ID: https://openalex.org/W4416671700

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4416671700

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.30707747

Digital Object Identifier
Title: Figure S5 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Work title
Type: article

OpenAlex work type
Publication year: 2025

Year of publication
Publication date: 2025-11-25

Full publication date if available
Authors: Galen Hostetter, Justin R. Kulchycki, R. Katherine Alpaugh, Candice L. Schwebel, Pooja Ghatalia, Jozef Madžo, Noah M. Hahn, Jean‐Pierre J. Issa, Stephen B. Baylin, Hui Shen, Peter A. Jones

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.30707747

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.30707747

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W4416671700
doi	https://doi.org/10.1158/1078-0432.30707747
ids.doi	https://doi.org/10.1158/1078-0432.30707747
ids.openalex	https://openalex.org/W4416671700
fwci	0.0
type	article
title	Figure S5 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
is_xpac	False
apc_list
apc_paid
language
locations[0].id	doi:10.1158/1078-0432.30707747
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.30707747
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5062941900
authorships[0].author.orcid	https://orcid.org/0000-0003-2616-6861
authorships[0].author.display_name	Galen Hostetter
authorships[0].author_position	middle
authorships[0].raw_author_name	Galen Hostetter
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5005720140
authorships[1].author.orcid	https://orcid.org/0000-0002-4000-9320
authorships[1].author.display_name	Justin R. Kulchycki
authorships[1].author_position	middle
authorships[1].raw_author_name	Justin R. Kulchycki
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5049901305
authorships[2].author.orcid	https://orcid.org/0000-0002-6775-5323
authorships[2].author.display_name	R. Katherine Alpaugh
authorships[2].author_position	middle
authorships[2].raw_author_name	R. Katherine Alpaugh
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5083779488
authorships[3].author.orcid	https://orcid.org/0000-0002-2788-3486
authorships[3].author.display_name	Candice L. Schwebel
authorships[3].author_position	last
authorships[3].raw_author_name	Candice L. Schwebel
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5079166812
authorships[4].author.orcid	https://orcid.org/0000-0001-6229-7581
authorships[4].author.display_name	Pooja Ghatalia
authorships[4].author_position	middle
authorships[4].raw_author_name	Pooja Ghatalia
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5014780308
authorships[5].author.orcid	https://orcid.org/0000-0001-6607-1213
authorships[5].author.display_name	Jozef Madžo
authorships[5].author_position	middle
authorships[5].raw_author_name	Jozef Madzo
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5001308517
authorships[6].author.orcid	https://orcid.org/0000-0002-1016-9024
authorships[6].author.display_name	Noah M. Hahn
authorships[6].author_position	middle
authorships[6].raw_author_name	Noah M. Hahn
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5062330946
authorships[7].author.orcid	https://orcid.org/0000-0003-2258-5030
authorships[7].author.display_name	Jean‐Pierre J. Issa
authorships[7].author_position	middle
authorships[7].raw_author_name	Jean-Pierre J. Issa
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5058612163
authorships[8].author.orcid	https://orcid.org/0000-0003-3697-3798
authorships[8].author.display_name	Stephen B. Baylin
authorships[8].author_position	middle
authorships[8].raw_author_name	Stephen B. Baylin
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5015458809
authorships[9].author.orcid	https://orcid.org/0000-0001-9767-4084
authorships[9].author.display_name	Hui Shen
authorships[9].author_position	middle
authorships[9].raw_author_name	Hui Shen
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5088347458
authorships[10].author.orcid	https://orcid.org/0000-0001-8309-4767
authorships[10].author.display_name	Peter A. Jones
authorships[10].author_position	middle
authorships[10].raw_author_name	Peter A. Jones
authorships[10].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.30707747
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-11-25T00:00:00
display_name	Figure S5 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
has_fulltext	False
is_retracted	False
updated_date	2025-11-28T20:17:09.762349
primary_topic
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.30707747
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.30707747
primary_location.id	doi:10.1158/1078-0432.30707747
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.30707747
publication_date	2025-11-25
publication_year	2025
referenced_works_count	0
abstract_inverted_index.5:	2
abstract_inverted_index.UC	15
abstract_inverted_index.in	11, 14
abstract_inverted_index.of	9
abstract_inverted_index.and	7
abstract_inverted_index.genes	13
abstract_inverted_index.tumor	4
abstract_inverted_index.Figure	1
abstract_inverted_index.burden	6
abstract_inverted_index.Overall	3
abstract_inverted_index.mutation	5
abstract_inverted_index.frequency	8
abstract_inverted_index.mutations	10
abstract_inverted_index.cancer-associated	12
abstract_inverted_index.tumors.</p>	16
abstract_inverted_index.<p>Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	11
citation_normalized_percentile